ROSEN, SKILLED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
If you purchased Novo Nordisk securities during the Class Period you may be entitled to compensation without payment of any ...
NVO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Novo Nordisk A/S Stockholders Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Euroinvestor7h
Investeringsøkonom: Dette kan forklare Novo Nordisk-aktiens kursnedtur
»Den fortsatte toldsnak er formentlig hovedårsagen til at Novo Nordisk underperformer. Investorer er her og nu nervøse for, hvad Donald Trump kan finde på, og vurderet efter kursudviklingen er det ...
pharmaphorum14h
Pfizer upgrades Biohaven alliance to a takeover bid
Not content with a $1.2 billion licensing deal for Biohaven Pharma's oral migraine therapy rimegepant, Pfizer has just offered to buy the company outright – for a cool $11.6 billion. Pfizer's ...